Bullboard - Stock Discussion Forum Hemostemix Inc V.HEM

Alternate Symbol(s): HMTXF

Healthcare Biotechnology

Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP... see more

Add To Watchlist

TSXV:HEM - Post Discussion

Hemostemix Inc > Hemostemix led last week’s top performers with a 50% gain

View:

Post by cmarketinsights on Oct 22, 2024 2:22pm

Hemostemix led last week’s top performers with a 50% gain

Hemostemix led last week’s top performers with a 50% gain. As highlighted last week, HEM is actively pursuing a $4M equity financing.

The company is making significant strides with ACP-01, its flagship product aimed at helping patients in critical need on a compassionate basis.

Hemostemix is initially focusing on patients with critical limb ischemia (CLI) and ischemic heart disease, two markets where there is a substantial demand for innovative treatments.

With financing efforts underway, the potential for scaling up production is on the horizon.

Read more commentary on Hemostemix and market insights in this weekly report from CFA-certified Analysts of Fundamental Research Corp: https://www.researchfrc.com/content/analyst-ideas/post/151/-weekly-highlights-top-performers-and-key-updates-in-resource-sector

104